Administration of Chinese Herbal Medicines Facilitates the Locomotor Activity in Dystrophin-Deficient Mice
- 1 January 2001
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 29 (2) , 281-292
- https://doi.org/10.1142/s0192415x01000307
Abstract
The purpose of this study was to access the effects of chinese herbal medicines on Duchenne muscular dystrophy (DMD). We use dystrophin-deficient mice (mdx), an animal model of DMD, to evaluate the effect of chinese herbal medicines on locomotor activity. The consumption of water for each mouse was controlled during the three-month experimental session. Each mouse was allowed to drink 3 ml water with or without herbal medicines daily for three months. The estimated intake of chinese herbal medicine in adult mdx mouse with 30 g weight is 100 mg/kg per day, close to a dose used in human. The locomotor activity of the mdx mice was measured every month. Monitoring the locomotor activity of mdx mice after three-month administration of chinese herbal medicines, the results showed that Liu-Wei-Di-Huang-Wan (LDW) and San-Lin-Pai-Tsu-San (SPS) can facilitate locomotor activity with the parameters of horizontal activity, total distance, number of movements, movement time, vertical activity, number of vertical movements, vertical movement time, stereotypy, number of stereotyped movements, and stereotyped movement time. These results suggest that either LDW or SPS can act as a potent herbal medicine for the pharmacological treatment of DMD patients.Keywords
This publication has 33 references indexed in Scilit:
- Mini- and full-length dystrophin gene transfer induces the recovery of nitric oxide synthase at the sarcolemma of mdx4cv skeletal muscle fibersGene Therapy, 1998
- Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophinActa Histochemica, 1996
- Site and mechanics of failure in normal and dystrophin‐deficient skeletal muscleMuscle & Nerve, 1995
- Invited Review. The potential for gene therapy in duchenne muscular dystrophy and other genetic muscle diseasesMuscle & Nerve, 1993
- Cloned human brain nitric oxide synthase is highly expressed in skeletal muscleFEBS Letters, 1993
- Direct visualization of the dystrophin network on skeletal muscle fiber membrane.The Journal of cell biology, 1992
- Retroviral‐mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitroFEBS Letters, 1992
- Letters to the editorMuscle & Nerve, 1989
- THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: II. CONTRACTILE PROPERTIESNeuropathology and Applied Neurobiology, 1988
- Characterization of Dystrophin in Muscle-Biopsy Specimens from Patients with Duchenne's or Becker's Muscular DystrophyNew England Journal of Medicine, 1988